Archives
-
CD80 mRNA: From Costimulation to Translation
2026-10-06
A translational framework for studying CD80-mediated immune costimulation with mRNA, linking mechanistic validation to the lessons of CAR T-cell and mRNA vaccine research while maintaining clear evidence boundaries.
-
Nanoparticle mRNA Delivery Reverses Trastuzumab Resistance
2026-10-06
The reference study presents a tumor-microenvironment-responsive nanoparticle platform for systemic PTEN mRNA delivery, aiming to restore pathway control in trastuzumab-resistant HER2-positive breast cancer. Its central contribution is the integration of pH-responsive tumor accumulation, intracellular mRNA release, PTEN restoration, and PI3K/Akt signaling pathway inhibition; the evidence remains preclinical and formulation-specific.
-
EZ Cap™ Human PTEN mRNA (ψUTP): Evidence to Model
2026-10-05
EZ Cap™ Human PTEN mRNA (ψUTP) offers a defined platform for studying PTEN restoration, mRNA stability enhancement, and PI3K/Akt signaling. This evidence-focused analysis separates what the product chemistry supports from what nanoparticle-based cancer studies actually demonstrate.
-
T0070907 and PPARγ Signaling: Evidence Overview
2026-10-05
T0070907 is a covalent PPARγ antagonist used as a research probe for receptor signaling, adipogenesis, inflammation, and cancer-associated cell-cycle effects. This overview compares supplier-reported pharmacology with findings from a 2025 berberine study of the RXRα/PPARγ/NEDD4 axis in atherosclerosis, emphasizing what the evidence supports, what remains indirect, and where interpretation should be cautious.
-
ROS-Responsive LNPs for Tumor-Selective mRNA Delivery
2026-10-04
Cai and colleagues developed a combinatorial library of thioketal-containing, ROS-degradable lipid nanoparticles to preferentially deliver mRNA into tumor cells. Their study identifies BAmP-TK-12 as a lead material and shows that delivery of DUF5-encoding mRNA can suppress mutant RAS signaling, while also highlighting important limits in selectivity, model scope, and translational evidence.
-
WST-8 and Diabetic Wound Hydrogel Evidence
2026-10-03
A source-grounded overview of what WST-8 viability data can show, how to interpret the reported hydrogel findings, and where evidence remains limited.
-
Red Blood Cell Membrane Bending Rigidity Explained
2026-10-01
Himbert et al. separated the intrinsic cytoplasmic membrane from the red blood cell spectrin network and measured its bending rigidity using X-ray diffuse scattering, neutron spin-echo spectroscopy, and molecular dynamics simulations. The study places the membrane-only bending modulus near 4–6 kBT, clarifying why measurements from intact red blood cells span a much wider range and why length scale is central to interpreting cell mechanics.
-
EZ Cap™ Human PTEN mRNA: Assay Logic
2026-10-01
Explore how EZ Cap™ Human PTEN mRNA (ψUTP) can be used to design mechanistically rigorous PTEN restoration studies. This article focuses on causal assay architecture, translational controls, delivery-aware interpretation, and the relevance of PI3K/Akt signaling pathway inhibition in cancer research.
-
EZ Cap™ Human PTEN mRNA (ψUTP) Workflow
2026-09-30
Build reproducible PTEN restoration assays with a Cap 1, pseudouridine-modified transcript designed for mammalian translation. This workflow distinguishes direct transfection from nanoparticle delivery and shows how to connect PTEN expression with PI3K/Akt signaling, resistance phenotypes, and practical troubleshooting.
-
DOPE Workflows for Lipid and Ferroptosis Assays
2026-09-30
Discover how DOPE supports endosomal escape in nucleic acid formulations and enables controlled phosphatidylethanolamine experiments in rice blast research. This workflow separates validated product-handling guidance from exploratory assays inspired by fungal IAA, lipid peroxidation, autophagy, and conidial-death findings.
-
4-Hydroxytamoxifen: Practical Protocol Guide
2026-09-29
4-Hydroxytamoxifen is an estrogen receptor modulator for DMSO-compatible cell, cardiac myocyte, cancer, and selected in vivo workflows. The APExBIO dossier supports its use as a solid stored at -20°C, but its insolubility in water and ethanol excludes aqueous-only or ethanol-only protocols.
-
Berberine–RXRα/PPARγ/NEDD4 Signaling in Atherosclerosis
2026-09-29
This 2025 study identifies an RXRα/PPARγ/NEDD4 axis through which berberine suppresses SASP-related inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of mouse disease modeling, foam-cell assays, Smart-seq analysis, and macrophage-specific RXRα knockdown provides a mechanistic framework for studying vascular inflammaging.
-
DOPE: A Causal Framework for Lipid Biology
2026-09-28
Explore how 1,2-Dioleoyl-sn-glycero-3-PE (DOPE) links membrane fusion, nucleic acid delivery, and phospholipid rescue experiments. This guide emphasizes how to interpret DOPE mechanistically rather than treating it as a generic formulation additive.
-
HyperFluor 488 Goat Anti-Rabbit IgG: Workflow Guide
2026-09-28
HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody detects rabbit primary antibodies in fluorescence-based assays and can support signal amplification. Use it for compatible immunofluorescence, flow cytometry, or fluorescence microscopy workflows—not as a primary antibody or a substitute for non-fluorescent detection reagents.
-
DMH-1: A Causal Probe for BMP-Driven Cell Fate
2026-09-27
DMH1 is a selective ALK2 inhibitor that can help researchers test how BMP signaling shapes intestinal organoid cell fate. This article connects a recent human organoid study to practical experimental decisions, while distinguishing pathway evidence from reagent-specific validation.